According to a new report, published by KBV research, The Global Chronic Disease Management Market size is expected to reach $9.9 billion by 2028, rising at a market growth of 11.7% CAGR during the forecast period.
The Services segment is showcasing a CAGR of 14% during (2022 - 2028). The market is expanding as a result of the rise in the prevalence of chronic diseases like diabetes, cardiovascular conditions, and other illnesses worldwide. In addition, many people are increasingly spending on the management of their chronic health conditions, which would escalate the growth of the segment.
The Healthcare Providers segment acquired maximum revenue share in the Global Chronic Disease Management Market by End User in 2021 thereby, achieving a market value of $5.2 billion by 2028. A rise in the incidence of long-term conditions like cancer, heart disease, asthma, diabetes, and chronic obstructive pulmonary disease. In order to offer more effective treatment choices for the management of chronic diseases, the need for health care services rises.
The Cardiovascular diseases segment has shown the growth rate of 12.2% during (2022 - 2028). The market is expanding as a result of a rise in the rate of cardiovascular disorders such as stroke, aortic aneurysms, arrhythmia, and others. According to estimates, 17.9 million deaths worldwide in 2019 were attributable to CVDs, or 32% of all fatalities. 85 percent of these fatalities were caused by heart attack and stroke.
The North America market dominated the Global Chronic Disease Management Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $3.65 billion by 2028. The Europe market is exhibiting a CAGR of 11.4% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 12.4% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/chronic-disease-management-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Infosys Limited, ExlService Holdings, Inc., Health Catalyst, Inc., AllScripts Healthcare Solutions, Inc., Koninklijke Philips N.V., Cognizant Technology Solutions Corporation, Casenet, LLC, Cedar Gate Technologies, Clinical Excellence, Inc., and Altruista Health, Inc.
By Type
By End User
By Disease Type
By Geography
Companies Profiled
Unique Offerings 
